mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
Cancer
DMS
G-quadruplexes
Hippuristanol
Polysome profiling
RNA structure
Structure-seq
Translation
Translation initiation
eIF4A
Journal
Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660
Informations de publication
Date de publication:
30 12 2019
30 12 2019
Historique:
received:
08
08
2019
accepted:
26
11
2019
entrez:
1
1
2020
pubmed:
1
1
2020
medline:
21
3
2020
Statut:
epublish
Résumé
The RNA helicase eIF4A1 is a key component of the translation initiation machinery and is required for the translation of many pro-oncogenic mRNAs. There is increasing interest in targeting eIF4A1 therapeutically in cancer, thus understanding how this protein leads to the selective re-programming of the translational landscape is critical. While it is known that eIF4A1-dependent mRNAs frequently have long GC-rich 5'UTRs, the details of how 5'UTR structure is resculptured by eIF4A1 to enhance the translation of specific mRNAs are unknown. Using Structure-seq2 and polysome profiling, we assess global mRNA structure and translational efficiency in MCF7 cells, with and without eIF4A inhibition with hippuristanol. We find that eIF4A inhibition does not lead to global increases in 5'UTR structure, but rather it leads to 5'UTR remodeling, with localized gains and losses of structure. The degree of these localized structural changes is associated with 5'UTR length, meaning that eIF4A-dependent mRNAs have greater localized gains of structure due to their increased 5'UTR length. However, it is not solely increased localized structure that causes eIF4A-dependency but the position of the structured regions, as these structured elements are located predominantly at the 3' end of the 5'UTR. By measuring changes in RNA structure following eIF4A inhibition, we show that eIF4A remodels local 5'UTR structures. The location of these structural elements ultimately determines the dependency on eIF4A, with increased structure just upstream of the CDS being the major limiting factor in translation, which is overcome by eIF4A activity.
Sections du résumé
BACKGROUND
The RNA helicase eIF4A1 is a key component of the translation initiation machinery and is required for the translation of many pro-oncogenic mRNAs. There is increasing interest in targeting eIF4A1 therapeutically in cancer, thus understanding how this protein leads to the selective re-programming of the translational landscape is critical. While it is known that eIF4A1-dependent mRNAs frequently have long GC-rich 5'UTRs, the details of how 5'UTR structure is resculptured by eIF4A1 to enhance the translation of specific mRNAs are unknown.
RESULTS
Using Structure-seq2 and polysome profiling, we assess global mRNA structure and translational efficiency in MCF7 cells, with and without eIF4A inhibition with hippuristanol. We find that eIF4A inhibition does not lead to global increases in 5'UTR structure, but rather it leads to 5'UTR remodeling, with localized gains and losses of structure. The degree of these localized structural changes is associated with 5'UTR length, meaning that eIF4A-dependent mRNAs have greater localized gains of structure due to their increased 5'UTR length. However, it is not solely increased localized structure that causes eIF4A-dependency but the position of the structured regions, as these structured elements are located predominantly at the 3' end of the 5'UTR.
CONCLUSIONS
By measuring changes in RNA structure following eIF4A inhibition, we show that eIF4A remodels local 5'UTR structures. The location of these structural elements ultimately determines the dependency on eIF4A, with increased structure just upstream of the CDS being the major limiting factor in translation, which is overcome by eIF4A activity.
Identifiants
pubmed: 31888698
doi: 10.1186/s13059-019-1901-2
pii: 10.1186/s13059-019-1901-2
pmc: PMC6936103
doi:
Substances chimiques
5' Untranslated Regions
0
Codon, Initiator
0
RNA, Messenger
0
Sterols
0
hippuristanol
0
Eukaryotic Initiation Factor-4A
EC 2.7.7.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
300Subventions
Organisme : Medical Research Council
ID : MC_UP_1203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A600_1024
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00025/6
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C20673/A24388
Pays : United Kingdom
Références
Cell Cycle. 2016 Sep 16;15(18):2405-9
pubmed: 27533468
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13421-6
pubmed: 25197055
Nat Struct Mol Biol. 2018 Aug;25(8):677-686
pubmed: 30061596
Nat Protoc. 2015 Jul;10(7):1050-66
pubmed: 26086407
Genome Res. 2016 May;26(5):636-48
pubmed: 26984228
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22217-22
pubmed: 20018725
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):510-520
pubmed: 28965870
Nucleic Acids Res. 2007;35(18):e121
pubmed: 17881372
J Biol Chem. 1983 Jun 10;258(11):7228-35
pubmed: 6853516
Front Oncol. 2017 Jul 26;7:158
pubmed: 28798901
Cell. 2008 Dec 26;135(7):1237-50
pubmed: 19109895
Nature. 2014 Sep 4;513(7516):105-9
pubmed: 25079330
BMC Bioinformatics. 2010 Mar 15;11:129
pubmed: 20230624
J Am Chem Soc. 2015 Jul 8;137(26):8521-5
pubmed: 26056849
Genome Biol. 2011;12(2):R13
pubmed: 21310039
J Biol Chem. 1999 Apr 30;274(18):12236-44
pubmed: 10212190
Trends Cell Biol. 2016 Dec;26(12):918-933
pubmed: 27426745
Nucleic Acids Res. 2000 Aug 1;28(15):2943-53
pubmed: 10908358
Nature. 2016 Jun 15;534(7608):558-61
pubmed: 27309803
Nature. 2009 Apr 2;458(7238):623-6
pubmed: 19270679
Nature. 2014 Jan 30;505(7485):696-700
pubmed: 24270811
Nucleic Acids Res. 2019 Sep 19;47(16):8785-8806
pubmed: 31299079
Cancer Discov. 2015 Jul;5(7):768-781
pubmed: 25934076
Clin Cancer Res. 2017 Jan 1;23(1):21-25
pubmed: 27789529
Genome Biol. 2014;15(10):476
pubmed: 25273840
Elife. 2016 Aug 05;5:
pubmed: 27494274
Proc Int Conf Intell Syst Mol Biol. 1994;2:28-36
pubmed: 7584402
EMBO J. 2012 Sep 12;31(18):3745-56
pubmed: 22872150
Biochem Soc Trans. 2016 Dec 15;44(6):1761-1768
pubmed: 27913687
Nature. 2014 Jan 30;505(7485):701-5
pubmed: 24336214
Mol Cell. 2019 Feb 21;73(4):738-748.e9
pubmed: 30595437
Bioinformatics. 2014 Jan 15;30(2):180-8
pubmed: 24281695
Nat Chem. 2014 Jan;6(1):75-80
pubmed: 24345950
Cancer Res. 2015 Jan 15;75(2):250-63
pubmed: 25593033
Nat Rev Drug Discov. 2015 Apr;14(4):261-78
pubmed: 25743081
Bioinformatics. 2017 Nov 15;33(22):3532-3537
pubmed: 29036425
Science. 2015 Jun 26;348(6242):1486-8
pubmed: 26113725
Elife. 2018 Oct 03;7:
pubmed: 30281017
Annu Rev Biochem. 2014;83:779-812
pubmed: 24499181
Eur J Biochem. 1977 Jan;72(2):323-30
pubmed: 319998
Genome Res. 2015 Aug;25(8):1196-205
pubmed: 26122911
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2424-32
pubmed: 22927429
Genetics. 2019 May;212(1):153-174
pubmed: 30902808
RNA Biol. 2017 Oct 3;14(10):1299-1305
pubmed: 28277937
Nature. 2014 Sep 4;513(7516):65-70
pubmed: 25079319
Translation (Austin). 2016 Jan 04;4(1):e1137381
pubmed: 27335721
RNA. 2006 May;12(5):851-61
pubmed: 16540693
Genes Dev. 2018 Aug 1;32(15-16):1060-1074
pubmed: 30042133
Science. 2016 Sep 23;353(6306):null
pubmed: 27708011
Cell Death Dis. 2015 Jan 22;6:e1603
pubmed: 25611378
Nucleic Acids Res. 2018 Apr 6;46(6):3075-3087
pubmed: 29471358
Methods Enzymol. 2000;318:479-93
pubmed: 10890007
Genes Dev. 2002 Nov 15;16(22):2906-22
pubmed: 12435632
Genome Biol. 2019 Feb 21;20(1):40
pubmed: 30791935
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Mol Cell. 2018 Dec 6;72(5):862-874.e5
pubmed: 30318442
Nature. 2018 Jul;559(7712):130-134
pubmed: 29950728
Elife. 2017 Nov 30;6:
pubmed: 29192585
Nat Rev Mol Cell Biol. 2010 Feb;11(2):113-27
pubmed: 20094052
Wiley Interdiscip Rev RNA. 2013 Jul-Aug;4(4):369-85
pubmed: 23606618
Nat Methods. 2017 Jan;14(1):75-82
pubmed: 27819661
Methods. 2018 Jul 1;143:12-15
pubmed: 29410279
RNA Biol. 2013 Jan;10(1):19-32
pubmed: 22995829
Angew Chem Int Ed Engl. 2016 Jul 25;55(31):8958-61
pubmed: 27355429
RNA. 2001 Mar;7(3):382-94
pubmed: 11333019
Nucleic Acids Res. 2017 Aug 21;45(14):e135
pubmed: 28637286
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6304-6309
pubmed: 28559306